BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21327990)

  • 1. Trypanosoma cruzi: evaluation of (-)-cubebin derivatives activity in the messenger RNAs processing.
    Andrade e Silva ML; Cicarelli RM; Pauletti PM; Luz PP; Rezende KC; Januário AH; da Silva R; Pereira AC; Bastos JK; de Albuquerque S; Magalhães LG; Cunha WR
    Parasitol Res; 2011 Aug; 109(2):445-51. PubMed ID: 21327990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs.
    Barbosa CF; Okuda ES; Chung MC; Ferreira EI; Cicarelli RM
    Braz J Med Biol Res; 2007 Jan; 40(1):33-9. PubMed ID: 17224994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi.
    de Souza VA; da Silva R; Pereira AC; Royo Vde A; Saraiva J; Montanheiro M; de Souza GH; da Silva Filho AA; Grando MD; Donate PM; Bastos JK; Albuquerque S; e Silva ML
    Bioorg Med Chem Lett; 2005 Jan; 15(2):303-7. PubMed ID: 15603944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the in vivo therapeutic properties of (-)-cubebin and (-)-hinokinin against Trypanosoma cruzi.
    Esperandim VR; da Silva Ferreira D; Rezende KC; Cunha WR; Saraiva J; Bastos JK; e Silva ML; de Albuquerque S
    Exp Parasitol; 2013 Apr; 133(4):442-6. PubMed ID: 23274812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi.
    Saraiva J; Vega C; Rolon M; da Silva R; E Silva ML; Donate PM; Bastos JK; Gomez-Barrio A; de Albuquerque S
    Parasitol Res; 2007 Mar; 100(4):791-5. PubMed ID: 17053932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi: establishment of permeable cells for RNA processing analysis with drugs.
    Ambrósio DL; Barbosa CF; Vianna VF; Cicarelli RM
    Mem Inst Oswaldo Cruz; 2004 Oct; 99(6):617-20. PubMed ID: 15558173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo and in Silico Trypanocidal Activity Evaluation of (-)-Cubebin Encapsulated in PLGA Microspheres as Potential Treatment in Acute Phase.
    Neres NBR; Montagnini D; Ferreira DS; Parreira RLT; Orenha RP; Lima TC; Molina EF; Cunha WR; Silva MLA; Esperandim VR
    Chem Biodivers; 2021 Jun; 18(6):e2100052. PubMed ID: 33905595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morpholino antisense oligo inhibits trans-splicing of pre-inositol 1,4,5-trisphosphate receptor mRNA of Trypanosoma cruzi and suppresses parasite growth and infectivity.
    Hashimoto M; Nara T; Mita T; Mikoshiba K
    Parasitol Int; 2016 Jun; 65(3):175-9. PubMed ID: 26680159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the spliced leader genes and transcripts in Trypanosoma cruzi.
    McCarthy-Burke C; Taylor ZA; Buck GA
    Gene; 1989 Oct; 82(1):177-89. PubMed ID: 2684773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo infection by Trypanosoma cruzi: a morphometric study of tissue changes in mice.
    Esperandim VR; da Silva Ferreira D; Sousa Rezende KC; Cunha WR; Saraiva J; Bastos JK; Andrade E Silva ML; de Albuquerque S
    Parasitol Res; 2013 Jan; 112(1):431-6. PubMed ID: 22837101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-Trypanosoma cruzi activity of derivatives from nor-lapachones and lapachones.
    da Silva Júnior EN; de Souza MC; Fernandes MC; Menna-Barreto RF; Pinto Mdo C; de Assis Lopes F; de Simone CA; Andrade CK; Pinto AV; Ferreira VF; de Castro SL
    Bioorg Med Chem; 2008 May; 16(9):5030-8. PubMed ID: 18378461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
    Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
    Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-protein complexes mediate in vitro capping of the spliced-leader primary transcript and U-RNAs in Trypanosoma cruzi.
    Zwierzynski TA; Buck GA
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5626-30. PubMed ID: 1829524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents.
    Mendoza-Martínez C; Correa-Basurto J; Nieto-Meneses R; Márquez-Navarro A; Aguilar-Suárez R; Montero-Cortes MD; Nogueda-Torres B; Suárez-Contreras E; Galindo-Sevilla N; Rojas-Rojas Á; Rodriguez-Lezama A; Hernández-Luis F
    Eur J Med Chem; 2015; 96():296-307. PubMed ID: 25899334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole.
    Luna KP; Hernández IP; Rueda CM; Zorro MM; Croft SL; Escobar P
    Biomedica; 2009 Sep; 29(3):448-55. PubMed ID: 20436996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the trypanocidal activity of lignans isolated from the leaves of Zanthoxylum naranjillo.
    Bastos JK; Albuquerque S; Silva ML
    Planta Med; 1999 Aug; 65(6):541-4. PubMed ID: 10483375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosoma cruzi.
    Saraiva VB; Gibaldi D; Previato JO; Mendonça-Previato L; Bozza MT; Freire-De-Lima CG; Heise N
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3472-7. PubMed ID: 12384352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequences involved in mRNA processing in Trypanosoma cruzi.
    Campos PC; Bartholomeu DC; DaRocha WD; Cerqueira GC; Teixeira SM
    Int J Parasitol; 2008 Oct; 38(12):1383-9. PubMed ID: 18700146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi.
    Tempone AG; Ferreira DD; Lima ML; Costa Silva TA; Borborema SET; Reimão JQ; Galuppo MK; Guerra JM; Russell AJ; Wynne GM; Lai RYL; Cadelis MM; Copp BR
    Eur J Med Chem; 2017 Oct; 139():947-960. PubMed ID: 28881289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
    Benaim B; Garcia CR
    Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.